Referrals
  
Department of Surgery
info@columbiasurgery.org Referrals Patient Clinician Researcher
Lung Transplant
Lung Diseases and Disorders
Treatment and Care
Patient Guide to Lung Transplantation
Four Steps to Successful Transplantation
Who is Eligible for Lung Transplantation
Pre-Transplant Evaluation
Waiting for Transplantation
When an Organ Becomes Available
Lung Transplant Surgery
Post-Transplant Recovery
Life After Transplantation
Follow-Up Care
Exercise Program
Staying in Touch with Your Transplant Team
Immunosuppression and Organ Rejection
Bronchoscopy/Lung Biopsy
Infections
Post-Transplant Medications
Nutritional Management After Transplantation
Health Care for Life
Support Services
Organ Donation
Research
Links
What’s New
Staff
Contact & Referrals

Lung Transplant
Lung Transplantation Patient GuideImmunosuppressant Medications After Lung Transplantation


OKT3 After Lung Transplantation

OKT3® (monoclonal antibody)
Purpose OKT3 is an immunosuppressive medicine that helps prevent organ rejection.
Dosage Administered intravenously only.

Adults: Usually receive 5 to 10mg per day over 7 to 14 days.

Children: Usually receive 2.5 to 5 mg per day over 7 to 14 days.
When The transplant team orders the medication and it will be administered by the nurse during your hospitalization.
Common Side Effects Fever, chills, flu-like symptoms, shortness of breath, headache, low blood pressure, joint pain, diarrhea.

Back to Medications List


















top
     Contact Us About Us  Ways to Give Site Map Disclaimer Find a Physician Patient Forms Intranet
©1999-2007. Columbia University Medical Center, Department of Surgery, New York, NY.
Columbia University Medical Center/ NewYork-Presbyterian Hospital
Columbia University Medical Center NewYork-Presbyterian Hospital